Singapore markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
38.32+0.79 (+2.10%)
At close: 04:00PM EDT
38.32 0.00 (0.00%)
After hours: 04:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 408.91M
Enterprise value 280.88M
Trailing P/E 4.12
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.38
Price/book (mrq)2.03
Enterprise value/revenue 0.26
Enterprise value/EBITDA 2.01

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 3-61.96%
S&P500 52-week change 329.57%
52-week high 3109.52
52-week low 334.09
50-day moving average 345.49
200-day moving average 370.49

Share statistics

Avg vol (3-month) 3385.05k
Avg vol (10-day) 3561.86k
Shares outstanding 510.9M
Implied shares outstanding 610.9M
Float 89.8M
% held by insiders 12.70%
% held by institutions 197.82%
Shares short (15 Mar 2024) 42.05M
Short ratio (15 Mar 2024) 43.92
Short % of float (15 Mar 2024) 428.57%
Short % of shares outstanding (15 Mar 2024) 418.81%
Shares short (prior month 15 Feb 2024) 41.89M

Dividends & splits

Forward annual dividend rate 46.6
Forward annual dividend yield 417.59%
Trailing annual dividend rate 34.95
Trailing annual dividend yield 313.19%
5-year average dividend yield 44.32
Payout ratio 454.40%
Dividend date 307 Nov 2023
Ex-dividend date 418 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.27%
Operating margin (ttm)4.54%

Management effectiveness

Return on assets (ttm)25.24%
Return on equity (ttm)55.77%

Income statement

Revenue (ttm)1.07B
Revenue per share (ttm)98.50
Quarterly revenue growth (yoy)-43.40%
Gross profit (ttm)N/A
EBITDA 139.51M
Net income avi to common (ttm)99.42M
Diluted EPS (ttm)9.10
Quarterly earnings growth (yoy)-77.20%

Balance sheet

Total cash (mrq)150.04M
Total cash per share (mrq)13.92
Total debt (mrq)22.01M
Total debt/equity (mrq)10.93%
Current ratio (mrq)2.43
Book value per share (mrq)18.69

Cash flow statement

Operating cash flow (ttm)147.66M
Levered free cash flow (ttm)106.22M